Ying P Tabak

Summary

Publications

  1. ncbi Candidemia on presentation to the hospital: development and validation of a risk score
    Andrew F Shorr
    Pulmonary and Critical Care Medicine Service, Washington Hospital Center, Washington, DC 20010, USA
    Crit Care 13:R156. 2009
  2. ncbi Development and validation of a disease-specific risk adjustment system using automated clinical data
    Ying P Tabak
    Biostatistics, Clinical Research, MedMined Services, CareFusion, 400 Nickerson Road, Marlborough, MA 01752, USA
    Health Serv Res 45:1815-35. 2010
  3. ncbi Using automated clinical data for risk adjustment: development and validation of six disease-specific mortality predictive models for pay-for-performance
    Ying P Tabak
    Department of Clinical Research, Cardinal Health s MediQual Business, Marlborough, MA 01752, USA
    Med Care 45:789-805. 2007
  4. ncbi Mortality and need for mechanical ventilation in acute exacerbations of chronic obstructive pulmonary disease: development and validation of a simple risk score
    Ying P Tabak
    Clinical Research Services, Cardinal Health, Marlborough, Massachusetts, USA
    Arch Intern Med 169:1595-602. 2009
  5. ncbi Should Do-Not-Resuscitate status be included as a mortality risk adjustor? The impact of DNR variations on performance reporting
    Ying P Tabak
    Department of Research, Cardinal Health Data and Clinical Information MediQual, Marlborough, Massachusetts 01752, USA
    Med Care 43:658-66. 2005

Detail Information

Publications5

  1. ncbi Candidemia on presentation to the hospital: development and validation of a risk score
    Andrew F Shorr
    Pulmonary and Critical Care Medicine Service, Washington Hospital Center, Washington, DC 20010, USA
    Crit Care 13:R156. 2009
    ..Candidemia results in substantial morbidity and mortality, especially if initial antifungal therapy is delayed or is inappropriate; however, candidemia is difficult to diagnose because of its nonspecific presentation...
  2. ncbi Development and validation of a disease-specific risk adjustment system using automated clinical data
    Ying P Tabak
    Biostatistics, Clinical Research, MedMined Services, CareFusion, 400 Nickerson Road, Marlborough, MA 01752, USA
    Health Serv Res 45:1815-35. 2010
    ..To assess the values of additional manually abstracted data...
  3. ncbi Using automated clinical data for risk adjustment: development and validation of six disease-specific mortality predictive models for pay-for-performance
    Ying P Tabak
    Department of Clinical Research, Cardinal Health s MediQual Business, Marlborough, MA 01752, USA
    Med Care 45:789-805. 2007
    ..We also evaluated the additional value of vital signs and altered mental status (Full Models)...
  4. ncbi Mortality and need for mechanical ventilation in acute exacerbations of chronic obstructive pulmonary disease: development and validation of a simple risk score
    Ying P Tabak
    Clinical Research Services, Cardinal Health, Marlborough, Massachusetts, USA
    Arch Intern Med 169:1595-602. 2009
    ..Acute exacerbations of chronic obstructive pulmonary disease (AECOPDs) often require hospitalization, may necessitate mechanical ventilation, and can be fatal. We sought to develop a simple risk score to determine its severity...
  5. ncbi Should Do-Not-Resuscitate status be included as a mortality risk adjustor? The impact of DNR variations on performance reporting
    Ying P Tabak
    Department of Research, Cardinal Health Data and Clinical Information MediQual, Marlborough, Massachusetts 01752, USA
    Med Care 43:658-66. 2005
    ..The practice of ordering "Do-Not-Resuscitate" (DNR) varies across hospitals. No research has explored how the DNR variation would affect cross-institutional performance reporting when DNR status is used as a risk adjustor...